Michael Garrison's most recent trade in Becton, Dickinson And Co. was a trade of 6,360 Stock Appreciation Rights done . Disclosure was reported to the exchange on July 18, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Becton, Dickinson & Company | Michael D. Garrison | EVP & President, Medical | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jul 2025 | 6,360 | 0 | - | - | Stock Appreciation Rights | |
Becton, Dickinson & Company | Michael D. Garrison | EVP & President, Medical | Exercise or conversion of derivative security received from the company (such as an option) at price $ 147.68 per share. | 18 Jul 2025 | 6,360 | 11,247 (0%) | 0% | 147.7 | 939,245 | Common Stock |
Becton, Dickinson & Company | Michael D. Garrison | EVP & President, Medical | Sale or transfer of securities back to the company at price $ 180.29 per share. | 18 Jul 2025 | 5,175 | 6,072 (0%) | 0% | 180.3 | 933,001 | Common Stock |
Becton, Dickinson & Company | Michael D. Garrison | EVP & President, Medical | Sale of securities on an exchange or to another person at price $ 180.29 per share. | 18 Jul 2025 | 1,184 | 4,888 (0%) | 0% | 180.3 | 213,463 | Common Stock |
Becton, Dickinson & Company | Michael D. Garrison | EVP & President, Medical | Sale of securities on an exchange or to another person at price $ 182.00 per share. | 18 Jul 2025 | 1 | 4,887 (0%) | 0% | 182 | 182 | Common Stock |
Becton, Dickinson & Company | Michael D. Garrison | EVP & President, Medical | Sale of securities on an exchange or to another person at price $ 197.28 per share. | 09 Apr 2025 | 479 | 4,887 (0%) | 0% | 197.3 | 94,497 | Common Stock |
Becton, Dickinson & Company | Michael D. Garrison | EVP & President Medical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Mar 2025 | 178 | 5,366 (0%) | 0% | 0 | Common Stock | |
Becton, Dickinson & Company | Michael D. Garrison | EVP & President, Medical | Sale of securities on an exchange or to another person at price $ 236.51 per share. | 17 Jan 2025 | 597 | 5,544 (0%) | 0% | 236.5 | 141,196 | Common Stock |
Becton, Dickinson & Company | Garrison Michael D. | EVP & President, Medical | Sale of securities on an exchange or to another person at price $ 223.33 per share. | 19 Dec 2024 | 2,838 | 6,141 (0%) | 0% | 223.3 | 633,811 | Common Stock |
Becton, Dickinson & Company | Michael Garrison | EVP & President, Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 10,004 | 10,004 | - | - | Stock Appreciation Rights | |
Becton, Dickinson & Company | Michael Garrison | EVP & President, Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 2,553 | 7,934 (0%) | 0% | 0 | Common Stock | |
Becton, Dickinson & Company | Michael Garrison | EVP & President, Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 2,275 | 10,209 (0%) | 0% | 0 | Common Stock | |
Becton, Dickinson & Company | Michael Garrison | EVP & President, Medical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2024 | 1,230 | 8,979 (0%) | 0% | 0 | Common Stock | |
Becton, Dickinson & Company | Michael Garrison | EVP & President Medical | Sale of securities on an exchange or to another person at price $ 232.81 per share. | 30 Apr 2024 | 1,715 | 5,381 (0%) | 0% | 232.8 | 399,269 | Common Stock |
Becton, Dickinson & Company | Michael Garrison | EVP & President Medical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Mar 2024 | 178 | 7,096 (0%) | 0% | 0 | Common Stock | |
Becton, Dickinson & Company | Garrison Michael | EVP & President Medical | Sale of securities on an exchange or to another person at price $ 232.46 per share. | 11 Dec 2023 | 1,239 | 7,274 (0%) | 0% | 232.5 | 288,018 | Common Stock |
Becton, Dickinson & Company | Michael Garrison | EVP & President Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 10,364 | 10,364 | - | - | Stock Appreciation Rights | |
Becton, Dickinson & Company | Michael Garrison | EVP & President Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 3,131 | 10,159 (0%) | 0% | 0 | Common Stock | |
Becton, Dickinson & Company | Michael Garrison | EVP & President Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 1,871 | 7,028 (0%) | 0% | 0 | Common Stock | |
Becton, Dickinson & Company | Michael Garrison | EVP & President Medical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2023 | 1,646 | 8,513 (0%) | 0% | 0 | Common Stock | |
Becton, Dickinson & Company | Michael Garrison | EVP & President Medical | Sale of securities on an exchange or to another person at price $ 277.13 per share. | 08 Aug 2023 | 1,300 | 5,157 (0%) | 0% | 277.1 | 360,269 | Common Stock |
Becton, Dickinson & Company | Michael Garrison | EVP & President Medical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Mar 2023 | 193 | 6,457 (0%) | 0% | 0 | Common Stock | |
Becton, Dickinson & Company | Michael Garrison | EVP & President Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 9,466 | 9,466 | - | - | Stock Appreciation Rights | |
Becton, Dickinson & Company | Michael Garrison | EVP & President Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 1,567 | 6,044 (0%) | 0% | 0 | Common Stock | |
Becton, Dickinson & Company | Michael Garrison | EVP & President Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 1,223 | 7,267 (0%) | 0% | 0 | Common Stock | |
Becton, Dickinson & Company | Michael Garrison | EVP & President Medical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2022 | 617 | 6,650 (0%) | 0% | 0 | Common Stock |